Detalhes do Documento

PyrGF and GSTLN peptides enhance pravastatin's inhibition of 3-hydroxy-3-methyl-glutaryl coenzyme

Autor(es): da Silva, Jaff Ribeiro [UNESP] ; de Cerqueira e Silva, Mariana Barros [UNESP] ; Philadelpho, Biane Oliveira ; de Souza, Victória Cruz ; dos Santos, Johnnie Elton Machado ; Castilho, Marcelo Santos ; de Souza Ferreira, Ederlan ; Cilli, Eduardo Maffud [UNESP]

Data: 2022

Identificador Persistente: http://hdl.handle.net/11449/233815

Origem: Oasisbr

Assunto(s): Bioactive peptides; Cholesterol; Concentration–response effect; HMGCoAR inhibitor; Molecular docking


Descrição

Made available in DSpace on 2022-05-01T10:35:01Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-12-01

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Fundação de Amparo à Pesquisa do Estado da Bahia

Two newly designed peptides, Pyr-GF and GSTLN, enhance pravastatin inhibition of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase (HMGCoAR). In silico experiments have demonstrated the interaction of these peptides with the catalytic and NADPH sites of HMGCoAR. In vitro, the Pyr-GF (IC50 = 117.4 μM) and GSTLN (IC50 = 278.1 μM) peptides exhibit dose-dependent inhibition on the HMGCoAR activity, and the effects are more significant than those observed for original peptides obtained from cowpea and adzuki beans. Compared to pravastatin alone, the Pyr-GF/pravastatin combination produced a small decrease (8%) in HMGCoAR activity, whereas the GSTLN/pravastatin combination produced a significant decrease of 41% on HMGCoAR activity. The association between Pyr-GF/GSTLN peptides decreased the IC50 to 71.8 μM. These results suggest their interaction with different sites; Pyr-GF and pravastatin mainly act on the catalytic site and GSTLN on the NADPH site. Hence, the Pyr-GF and GSTLN peptides and their combination exhibit a cholesterol-lowering effect and act as adjuvants upon association with pravastatin.

Institute of Chemistry São Paulo State University UNESP, Rua Prof. Francisco Degni

School of Pharmacy Federal University of Bahia, Barão de Jeremoabo Street

Institute of Chemistry São Paulo State University UNESP, Rua Prof. Francisco Degni

CAPES: 11671/2015

FAPESP: 2013/07600-3

FAPESP: 2014/50926-0

CNPq: 301975/2018-3

CNPq: 426235/2016-9

Fundação de Amparo à Pesquisa do Estado da Bahia: BOL0111/2020

Fundação de Amparo à Pesquisa do Estado da Bahia: BOL1867/2018

Fundação de Amparo à Pesquisa do Estado da Bahia: BOL2006/2019

Tipo de Documento Artigo científico
Idioma Inglês
facebook logo  linkedin logo  twitter logo 
mendeley logo

Documentos Relacionados

Não existem documentos relacionados.